medigraphic.com

2006, Number S2

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2006; 44 (S2)

Evidence-based transfusion medicine

Rodríguez MH

Language: Spanish
References: 12
Page: 115-118
PDF size: 75.75 Kb.


ABSTRACT

Evidence-based medicine (EBM) is the conscientious, explicit and judicious use of the best current evidences when making decisions about the care of individual patients. It is not restricted to specific evidences, such as therapeutic results, but any clinical evidence generated by methodological research (random studies on cohorts, including a placebo one). EBM is not restricted to randomized trials and meta-analyses. For example, to find out about the accuracy of a diagnostic test, we need to find proper cross-sectional studies of patients in which such disorder could be taking place. Evidence-based transfusion medicine necessarily implies the application of these concepts in the following:

• Prevention of its risks
• Avoidance of its unjustified use
• Definition of its justifying concepts in agreement with all the areas involved in the transfusion process
• Raise in the healthcare costs
• Better knowledge of transfusion risks by general population
• Consequently, lawsuits for blood transfusion damage

Several studies have been made to have evidences that prove a better evolution for the patient. Nevertheless, there is also evidence that mortality at intensive care units is greater when red blood cells have been transfused.


REFERENCES

  1. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence-Based Medicine: What is and what it isn´t. Brit Med J 1996;312:72-73.

  2. Segal J, Dzik W on Behalf of the Transfusion/Hemostasis Clinical Trials Network. Transfusion 2005;45:1413-1425.

  3. Hardy JF, de Moerloose P, Samama CM. The Coagulopathy of massive Transfusion. Vox Sanguinis 2005;89:123-127.

  4. Blajchman MA. Landmark Studies that have changed the practice of transfusion medicine. Transfusion 2005;45:1523-1530.

  5. Hebert PC, Wells G, Blajchman MA, et al. A multicenter randomized controlled trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-417.

  6. Goodnough LT. Mencionado en: Manejo de la sangre. Un acercamiento multidisciplinario hacia el paciente para reducir al mínimo las transfusiones. AABB News. July/August 2005. p. 20-23.

  7. A Multi-disciplinary, Patient-centered Approach to Minimizing Transfusions Blood Management. AABB News July/August 2005. p 20-23.

  8. Grover M, Talwalkar S, Casbard A, Boralessa H, et al. Silent myocardial ischaemia and haemoglobine concentration: a randomized controlled trial of transfusions strategy in lower limb arthroplasty. Vox Sanguinis 2006;90:105-112.

  9. TRAP Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractories to platelet transfusions N Engl J Med 1997;337:1861-1869.

  10. Van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leucocyte depletion of transfused blood on post-operative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998; 97:562-568.

  11. Billote DB, Glysson SN, Green D, et al. A prospective randomized study of preoperative autologous donation for hip replacement surgery J Bone Joint Surg Am 2002;8:1299-1304.

  12. Heddle NM, Klama L, Singer J, et al. The Role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-628.




2020     |     www.medigraphic.com